A recent study from the Mayo Clinic has found that hormone therapy, a treatment often used during menopause, may help women lose more weight when combined with a modern weight-loss medication. This discovery could change how doctors treat obesity in women after menopause.
After menopause, many women notice changes in their bodies. One of the most common changes is weight gain. This happens partly because estrogen levels drop, which can slow metabolism and change how fat is stored in the body.
As a result, women may find it harder to lose weight and easier to gain it. This can increase the risk of conditions such as heart disease and diabetes.
Hormone therapy is widely used to reduce menopause symptoms like hot flashes, night sweats, and sleep problems. These symptoms affect a large number of women and can make daily life uncomfortable. While hormone therapy is effective for symptom relief, its role in weight control has been less clear.
In recent years, new medications for weight loss have become available. One of the most effective is tirzepatide, which helps reduce appetite and improve blood sugar control. Many people have seen significant weight loss with this medication, but researchers wanted to know if its effects could be improved even further.
To explore this question, the research team studied 120 adults who were taking tirzepatide for at least 12 months. They compared women who were also using hormone therapy with those who were not. Both groups were similar in terms of age, weight, and health conditions at the beginning of the study.
The findings were striking. Women who used hormone therapy along with tirzepatide lost much more weight than those who used the medication alone. On average, the difference was about 35 percent more weight loss. This suggests that hormone therapy may enhance the effect of the drug.
The study was published in The Lancet Obstetrics, Gynaecology, & Women’s Health. The researchers believe that this combination may offer a more effective approach for managing weight and reducing health risks in postmenopausal women.
There are several possible reasons for this result. Hormone therapy may improve sleep and reduce discomfort from menopause symptoms, making it easier for women to follow healthy habits. It may also have direct effects on the body that support weight loss. Some early scientific studies suggest that estrogen may strengthen the appetite control effects of drugs like tirzepatide.
Despite these promising findings, the researchers caution that more work is needed. This study was observational, which means it can show a link but cannot prove that one treatment caused the other effect. Other factors, such as lifestyle differences, may have influenced the results.
The research team plans to carry out randomized clinical trials in the future. These studies will help confirm whether hormone therapy truly enhances weight loss and whether it also improves other health outcomes, such as heart health and blood sugar control.
This study is important because it focuses on a group that is often overlooked in weight-loss research. Women after menopause face unique challenges, and they may benefit from treatments tailored to their specific needs.
From a critical point of view, the study offers valuable insights but also has clear limitations. The number of participants is modest, and the design does not allow strong conclusions about cause and effect.
However, the consistency of the results and the size of the weight loss difference make the findings worth further investigation. If confirmed, this approach could lead to better and more personalized care for millions of women.
If you care about weight loss, please read studies that hop extract could reduce belly fat in overweight people, and early time-restricted eating could help lose weight .
For more health information, please see recent studies about a simple path to weight loss, and results showing a non-invasive treatment for obesity and diabetes.
Source: Mayo Clinic.
